Literature DB >> 31975487

Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk.

Ruth Dobson1,2, Mark Jitlal1, Charles R Marshall1,2, Alastair J Noyce1,2, John Robson3, Jack Cuzick1, Gavin Giovannoni1,2,4.   

Abstract

OBJECTIVE: Epidemiological research in multiple sclerosis (MS) has mainly been performed in socioeconomically and ethnically limited populations; influences on MS risk have not been studied in prospectively collected non-White populations. We set out to study the influence of previously described MS risk factors in an ethnically diverse population.
METHODS: A nested case-control study was created using primary care records of >1 million individuals, >50% of whom identify as Black, Asian, and Minority Ethnic (BAME). MS cases were compared to an age- and sex-matched control cohort (1:4), and to a large unmatched cohort. Odds ratios (ORs) of disease were determined according to exposure of interest, and a multivariate model including all exposures was created. Potential pairwise interactions were considered where both indicated a significant effect.
RESULTS: A total of 1,344 confirmed MS cases were included. MS OR in blacks aged <40 years was 1.15 (95% confidence interval [CI] = 0.81-1.62) compared to whites. MS odds in BAME current (OR = 1.71, 95% CI = 1.24-2.31) and ex-smokers (OR = 2.83, 95% CI = 2.14-3.72) were considerably higher than in Whites (OR = 1.09, 95% CI = 0.88-1.34; OR = 1.44, 95% CI = 1.19-1.74, respectively). Prior infectious mononucleosis was associated with increased odds of MS in Blacks (OR = 4.94, 95% CI = 1.23-17.89). An increase in MS odds was seen in the least-deprived quintile (OR = 2.46, 95% CI = 1.40-4.24), but no effect across deprived quintiles was seen.
INTERPRETATION: This cohort provides novel data on factors potentially driving MS susceptibility in a diverse population, one-third of whom live in poverty. Environmental exposures have differential risk across ethnicity. ANN NEUROL 2020;87:599-608.
© 2020 American Neurological Association.

Entities:  

Year:  2020        PMID: 31975487     DOI: 10.1002/ana.25688

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis.

Authors:  Devi Sai Sri Kavya Boorgu; Shruthi Venkatesh; Chirag M Lakhani; Elizabeth Walker; Ines M Aguerre; Claire Riley; Chirag J Patel; Philip L De Jager; Zongqi Xia
Journal:  Mult Scler Relat Disord       Date:  2022-06-24       Impact factor: 4.808

Review 2.  Towards a global view of multiple sclerosis genetics.

Authors:  Huw R Morris; Ruth Dobson; Benjamin Meir Jacobs; Michelle Peter; Gavin Giovannoni; Alastair J Noyce
Journal:  Nat Rev Neurol       Date:  2022-09-08       Impact factor: 44.711

3.  Association of Infectious Mononucleosis in Childhood and Adolescence With Risk for a Subsequent Multiple Sclerosis Diagnosis Among Siblings.

Authors:  Yin Xu; Ayako Hiyoshi; Kelsi A Smith; Fredrik Piehl; Tomas Olsson; Katja Fall; Scott Montgomery
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 4.  Epidemiology of Ocular Manifestations in Autoimmune Disease.

Authors:  Katie Glover; Deepakkumar Mishra; Thakur Raghu Raj Singh
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

5.  Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom.

Authors:  Ashvin Kuri; Benjamin Meir Jacobs; Nikki Vickaryous; Julia Pakpoor; Jaap Middeldorp; Gavin Giovannoni; Ruth Dobson
Journal:  BMC Public Health       Date:  2020-06-12       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.